A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement

about

Clinical Efficacy and Safety of Naftopidil Treatment for Patients with Benign Prostatic Hyperplasia and Hypertension: A Prospective, Open-Label Study Ten years of intraoperative floppy iris syndrome in the era of α-blockers.

P2860

Q33735007-AE85D2C1-B080-46F1-87EC-6852793A43AD Q55364267-20066B4A-9C80-45A9-B614-8F4F1948D86E

P2860

A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement

Item

http://www.wikidata.org/entity/Q41859727

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A comparison of the efficacy o ...... f benign prostatic enlargement

@en

type

Item

label

A comparison of the efficacy o ...... f benign prostatic enlargement

@en

prefLabel

A comparison of the efficacy o ...... f benign prostatic enlargement

@en

P1476

A comparison of the efficacy o ...... f benign prostatic enlargement

@en

P2093

Chenthil Perumal

http://www.w3.org/2001/XMLSchema#string

N Ananthakrishnan

http://www.w3.org/2001/XMLSchema#string

Prasant Nayak

http://www.w3.org/2001/XMLSchema#string

Puskar Shyam Chowdhury

http://www.w3.org/2001/XMLSchema#string

Srinivasan Gurumurthy

http://www.w3.org/2001/XMLSchema#string

P2860

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations.

Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia.

Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia.

Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system.

Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.

The use of alpha-adrenergic blockers in benign prostatic obstruction.

Modulation of bladder alpha1-adrenergic receptor subtype expression by bladder outlet obstruction.

International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update.

Long-term treatment and prognostic factors of alpha 1-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: a pilot study comparing naftopidil and tamsulosin hydrochloride.

Potential mechanisms of action of superselective alpha(1)-adrenoceptor antagonists.

P304

74-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0974-7796.148624

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272078319

http://www.w3.org/2001/XMLSchema#string

P698

25657550

http://www.w3.org/2001/XMLSchema#string

P932

4310123

http://www.w3.org/2001/XMLSchema#string

A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement

about

P2860

P2860

A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932